Ultra-Early Cancer Gene Screening

This test uses cutting-edge molecular diagnostics to detect gene mutations and biomarkers associated with early-stage or pre-cancerous changes—often before symptoms occur. It is highly effective for cancer prevention, early detection, and identifying hereditary cancer risks within families.

Screening Process:

cfDNA < 0.1: No pathological significance; retest every 6–12 months.
cfDNA 0.1–1: Suggestive of pathological changes; continued monitoring recommended.
CTC Screening Recommended: For individuals with existing diseases, family history, or high concern about hereditary cancer. If CTC is positive, a full-body MRI is advised.

What’s Included in the Test:

ctDNA Analysis: Detects over 100 types of cancers with ultra-high sensitivity (up to 99.99% accuracy), using WGS/WES/NGS and biomarkers like cfDNA.
B1-B4 Testing Panels: Options range from broad cancer screening to targeted gene mutation testing using PCR, digital PCR, and NGS technologies.

Who Should Consider This Test

High-Risk Individuals: With family history or hereditary cancer syndromes (e.g., BRCA1/2, pancreatic cancer carriers). Adults 50+: Especially with risk factors like smoking, obesity, or poor lifestyle habits. Chronic Virus Carriers: Increased risk due to long-term infections or hematologic conditions. Occupational Exposure: Long-term exposure to carcinogens in work or daily environments. Preventive Care Seekers: Individuals looking to take early action through personalized cancer prevention.

Appointment

Schedule your consultation

Rejuvenate Your Health and Vitality!

We help you revitalize your body’s natural energy and vitality through scientifically designed health management plans, enabling you to live a healthier and more confident life.